Staar Surgical Co.: FDA filings under this applicant name
FDA lists 24 510(k) clearances under 2 spellings of the applicant name “Staar Surgical Co.” (first 1983, latest 2017), plus 3 PMA decisions, across 11 product codes in 2 review panels. Median 510(k) review time under this name: 78 days. Related companies, subsidiaries and acquired businesses that file under other applicant names are counted on their own pages, not here.
510(k) clearances per year
| Year | Clearances | Median review days |
|---|---|---|
| 2012 | 0 | — |
| 2013 | 0 | — |
| 2014 | 0 | — |
| 2015 | 1 | 71 |
| 2016 | 0 | — |
| 2017 | 1 | 30 |
| 2018 | 0 | — |
| 2019 | 0 | — |
| 2020 | 0 | — |
| 2021 | 0 | — |
| 2022 | 0 | — |
| 2023 | 0 | — |
| 2024 | 0 | — |
| 2025 | 0 | — |
| 2026 | 0 | — |
Review time against the same product codes
Since 2017, 510(k)s cleared under the name Staar Surgical Co. took a median 30 days from FDA receipt to decision. All cleared 510(k)s in the same product codes over the same years took a median 195 days.
Top product codes
| Product code | Device | Submissions | 510(k) clearances |
|---|---|---|---|
| KYB | Lens, Guide, Intraocular | 7 | 7 |
| HQC | Unit, Phacofragmentation | 6 | 6 |
| MSS | Folders And Injectors, Intraocular Lens (Iol) | 5 | 5 |
| HQL | Intraocular Lens | 2 | 1 |
| HNR | Forceps, Ophthalmic | 1 | 1 |
| HQE | Instrument, Vitreous Aspiration And Cutting, Ac-Powered | 1 | 1 |
| JSM | Culture Media, Non-Propagating Transport | 1 | 1 |
| KYF | Implant, Eye Valve | 1 | 1 |
| KYG | Device, Irrigation, Ocular Surgery | 1 | 1 |
| MTA | Lens, Intraocular, Phakic | 1 | 0 |
Plus 1 more product codes.
Review panels
- Ophthalmic (25)
- Microbiology (1)
Most recent Staar Surgical Co. 510(k) clearances
| 510(k) | Device | Product code | Decision date | Review days |
|---|---|---|---|---|
| K172375 | MicroSTAAR Injector System Cartridges | MSS | 2017-09-06 | 30 |
| K152357 | MicroSTAAR Injector System Cartridges | KYB | 2015-10-30 | 71 |
| K090161 | EPIPHANY INJECTION SYSTEM | MSS | 2009-06-09 | 138 |
| K073591 | MICROSTAAR MSI INJECTOR FOAM TIP SYSTEM | MSS | 2008-03-13 | 84 |
| K073586 | MICROSTAAR INDIGO INJECTOR FOAM TIP SYSTEM | MSS | 2008-03-13 | 84 |
| K032412 | RE-USEABLE MICROSTAAR INJECTOR, MSI-S | KYB | 2004-06-10 | 310 |
| K020734 | SURGE-FREE ASPIRATION ADAPTER | HQC | 2002-05-16 | 71 |
| K983129 | DISPOSABLE MICROSTAAR INJECTOR (MODEL MSI-P1) | KYB | 1998-12-04 | 87 |
| K980696 | FOAM TIP INJECTOR | MSS | 1998-09-11 | 200 |
| K954600 | MICROSTAAR INJECTOR MODELS MSI-TD & MSI-PD (MODIFICATION) | KYB | 1995-12-21 | 87 |
14 earlier clearances. See the full list in Caduvo.
PMA and De Novo decisions
| Number | Pathway | Device | Decision date |
|---|---|---|---|
| P030016 | PMA | VISIAN ICL (IMPLANTABLE COLLAMER LENS) | 2005-12-22 |
| P900048 | PMA | ELASTIMIDE(TM) SILICONE MODIFIED J-LOOP POST. CHAM | 1991-09-17 |
| P880091 | PMA | ELASTIC UVA PC IOL. | 1991-09-16 |
Recalls
22 product recalls in 11 recall events; 11 initiated in the last five years. Most recent: 2023-09-29.
2 product recalls in 2 recall events filed under other recalling-firm names cite a 510(k) or PMA held under this applicant name; 2 initiated in the last five years. Most often: Staar Surgical AG (2).
These recall records list the clearance number, so the device was cleared under this name. The recalling firm may be the same company under another spelling, a company that acquired the product line, a relabeler or a contract manufacturer. They are not added to the count above.
Recalling firms are matched to this applicant name by name only (same normalization), so related entities that recall under another name are not counted. A recall count says nothing about how safe one company's devices are compared with another's.
Device clinical trials
An industry sponsor named Staar Surgical Co. is the lead sponsor of 7 device studies on ClinicalTrials.gov (2 active or recruiting). Most recent:
- NCT07791381: Study of an Implantable Collamer Lens (ICL) (Not yet recruiting, started 2026-11)
- NCT07790965: Study of a Phakic Implantable Collamer Lens (ICL) (Not yet recruiting, started 2026-11)
- NCT05538754: Post-Market Evaluation of the EVO ICL (Completed, started 2022-09-23)
- NCT07291739: A Clinical Evaluation of a Phakic Intraocular Lens (Completed, started 2022-08-22)
- NCT04516772: STAAR Visian Toric ICL Post-Approval Study (Completed, started 2020-07-21)
SEC filings
STAAR SURGICAL CO (STAA): EDGAR filings, CIK 718937. An SEC registrant with the same name, matched by name only.
FDA spellings included
FDA records this applicant under 2 spellings (case, punctuation and legal-suffix variants of one name); this page adds them up. Filings per spelling:
- Staar Surgical Co. (24)
- STAAR Surgical Company (3)
Other FDA applicant names starting with the same word
FDA records these as separate applicants. Some may belong to the same corporate group and some may not; their filings are not included in the counts above.
- Staar Sugical (1 510(k)s)
- Staar Japan (1 510(k)s)
Frequently asked questions
How many FDA 510(k) clearances are listed under Staar Surgical Co.?
FDA lists 24 510(k) clearances under 2 spellings of the applicant name “Staar Surgical Co.” (first 1983, latest 2017), plus 3 PMA decisions, across 11 product codes in 2 review panels. Filings under other applicant names, such as subsidiaries, are not included.
How long has FDA taken to clear 510(k)s filed by Staar Surgical Co.?
The median time from FDA receipt to decision across 510(k)s cleared under the name Staar Surgical Co. is 78 days.
Which FDA product codes appear under Staar Surgical Co.?
The most frequent FDA product codes under this applicant name are KYB (Lens, Guide, Intraocular, 7); HQC (Unit, Phacofragmentation, 6); MSS (Folders And Injectors, Intraocular Lens (Iol), 5).
Next steps
- See all 24 Staar Surgical Co. clearances with predicates and recalls
- Run predicate analysis for product code KYB, Staar Surgical Co.'s most frequent
Compiled by Caduvo from public U.S. government records. Counts cover filings under the applicant names shown on this page only. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA or any other agency, or by the companies named. Not regulatory advice. Report an error in this data. Data and corrections policy.